Objective: To compare the efficacy and tolerability of a salmeterol/fluticasone propionate (FP) combination product (50/100µg twice daily) with budesonide (BUD) at a four-fold higher microgram ...

Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate (Seretide™ or Advair ®) is low. However, when asthma control deteriorates ...

Fluticasone propionate, salmeterol (as xinafoate); 45mcg/21mcg, 115mcg/21mcg, 230mcg/21mcg; per inh; metered-dose inhaler; CFC-free. Store at room temperature between 68° F and 77° F (20° C and ...

Teva has launched new digital inhaler and ... generic version of GlaxoSmithKline’s blockbuster inhaler Advair (fluticasone+salmeterol). The competition for the product approved in asthma ...

Fluticasone propionate, salmeterol (as xinafoate) 55mcg/14mcg, 113mcg/14mcg, 232mcg/14mcg; per actuation; dry pwd for oral inh with a dose counter; contains lactose. Increased risk of asthma ...

A leader in CNS specialty medicine sales in the United States and in the top five globally, Teva Pharmaceuticals is actively looking to expand its CNS portfolio further.

Salmeterol is used as a long-term (maintenance ... chronic obstructive pulmonary disease). Fluticasone is used to treat seasonal and year-round allergy symptoms such as stuffy/runny nose, itching ...

Teva Pharmaceuticals and Sanofi have concluded a collaboration deal for co-developing and co-commercialising the anti-tumour necrosis factor-like ligand 1A (TL1A) therapy, TEV’574. The therapy ...

Teva's trials showed 'overall drug liking' was also significantly lower for finely-crushed CEP-33237 compared to standard immediate release (IR) hydrocodone and a competitor product.

Bullish option flow detected in Teva (TEVA) with 19,998 calls trading, 4x expected, and implied vol increasing over 1 point to 49.09%. 11/1 weekly 19 calls and Jan-25 25 calls are the most active ...

MONTPELLIER, France--(BUSINESS WIRE)--Teva presented at ECNP 2024 * new positive efficacy, safety, and tolerability results for Phase 3 SOLARIS trial evaluating Olanzapine LAI (TV-‘749 / mdc-TJK ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...